This list is an analysis based on recent market events. It's not an investment recommendation.
Nextel Medical Corp., a clinical stage biotechnology company, develops ways to exploit the therapeutic potential of exosomes for the field of oncology in the United States. The company was formerly known as Exousia Pro, Inc. and changed its name to Nextel Medical Corp. in April 2026. Nextel Medical Corp. was incorporated in 2010 and is based in Saint Petersburg, Florida.
FAQs
What is Exousia Pro stock price today?▼
The current price of MAJI is $0.00 USD — it has increased by +20% in the past 24 hours. Watch Exousia Pro stock price performance more closely on the chart.
What is Exousia Pro stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Exousia Pro stocks are traded under the ticker MAJI.
Is Exousia Pro stock price growing?▼
MAJI stock has risen by +20% compared to the previous week, the month change is a -10% fall, over the last year Exousia Pro has showed a -95.76% decrease.
What is Exousia Pro market cap?▼
Today Exousia Pro has the market capitalization of 321,699.6
What is Exousia Pro revenue for the last year?▼
Exousia Pro revenue for the last year amounts to 1,000 USD.
What is Exousia Pro net income for the last year?▼
MAJI net income for the last year is -330,000 USD.
How many employees does Exousia Pro have?▼
As of November 2, 2026, the company has 1 employees.
In which sector is Exousia Pro located?▼
Exousia Pro operates in the Health & Wellness sector.
When did Exousia Pro complete a stock split?▼
The last stock split for Exousia Pro was on November 15, 2022 with a ratio of 1:20.
Where is Exousia Pro headquartered?▼
Exousia Pro is headquartered in Saint Petersburg, United States.